ICH
ICH Q10 Annex 1
Annex 1
조항 원문
Potential Opportunities to Enhance Science and Risk Based Regulatory Approaches * *Note: This annex reflects potential opportunities to enhance regulatory approaches.
The actual regulatory process will be determined by region.
Scenario Potential Opportunity
1. Comply with GMPs Compliance – status quo
2. Demonstrate effective Opportunity to: pharmaceutical quality system, • increase use of risk based including effective use of quality approaches for regulatory risk management principles (e.g., inspections. ICH Q9 and ICH Q10).
3. Demonstrate product and process Opportunity to: understanding, including effective • facilitate science based use of quality risk management pharmaceutical quality principles (e.g., ICH Q8 and ICH assessment; Q9). • enable innovative approaches to process validation;
• establish real-time release mechanisms.
4. Demonstrate effective Opportunity to: pharmaceutical quality system • increase use of risk based and product and process approaches for regulatory understanding, including the use inspections; of quality risk management • facilitate science based principles (e.g., ICH Q8, ICH Q9 pharmaceutical quality and ICH Q10). assessment;
• optimise science and risk based post-approval change processes to maximise benefits from innovation and continual improvement;
• enable innovative approaches to process validation;
• establish real-time release mechanisms.
본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.
출처: International Council for Harmonisation (ICH) · © ICH. Per the legal notice in each guideline, the document may be used, reproduced and distributed provided ICH's copyright is acknowledged; any adaptation or translation must be labelled as such and must not imply ICH endorsement. · 수집일 2026-11-15